Public Employees Retirement System of Ohio Sells 3,839 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Public Employees Retirement System of Ohio decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,053 shares of the medical device company's stock after selling 3,839 shares during the period. Public Employees Retirement System of Ohio's holdings in Cooper Companies were worth $6,164,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Cooper Companies in the 4th quarter valued at about $691,000. Highland Capital Management LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $4,004,000. Caprock Group LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $282,000. Entropy Technologies LP purchased a new position in Cooper Companies in the 4th quarter valued at approximately $248,000. Finally, Lecap Asset Management Ltd. increased its stake in Cooper Companies by 33.1% in the 4th quarter. Lecap Asset Management Ltd. now owns 11,955 shares of the medical device company's stock valued at $1,099,000 after purchasing an additional 2,974 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a research report on Friday. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a research note on Friday. BNP Paribas raised Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus target price of $100.38.

Cooper Companies Stock Down 13.8%

Shares of COO stock traded down $11.02 on Friday, hitting $68.94. 8,291,770 shares of the stock were exchanged, compared to its average volume of 1,531,454. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $13.79 billion, a P/E ratio of 35.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The business has a 50-day moving average of $79.82 and a 200 day moving average of $88.29. The Cooper Companies, Inc. has a fifty-two week low of $65.95 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the prior year, the company posted $0.85 earnings per share. Cooper Companies's revenue was up 6.3% on a year-over-year basis. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.